WO2001051064A8 - Ph-regulators against oral stereotypies in equines - Google Patents
Ph-regulators against oral stereotypies in equinesInfo
- Publication number
- WO2001051064A8 WO2001051064A8 PCT/GB2001/000099 GB0100099W WO0151064A8 WO 2001051064 A8 WO2001051064 A8 WO 2001051064A8 GB 0100099 W GB0100099 W GB 0100099W WO 0151064 A8 WO0151064 A8 WO 0151064A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- equines
- against oral
- stereotypies
- oral stereotypies
- regulators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU28620/01A AU2862001A (en) | 2000-01-15 | 2001-01-12 | Oral stereotypies |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0000859.9 | 2000-01-15 | ||
GB0000859A GB2358136A (en) | 2000-01-15 | 2000-01-15 | A medicament for the treatment of equine oral stereotypies using a pH regulator |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001051064A1 WO2001051064A1 (en) | 2001-07-19 |
WO2001051064A8 true WO2001051064A8 (en) | 2001-10-25 |
Family
ID=9883704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/000099 WO2001051064A1 (en) | 2000-01-15 | 2001-01-12 | Ph-regulators against oral stereotypies in equines |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2862001A (en) |
GB (1) | GB2358136A (en) |
WO (1) | WO2001051064A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030235628A1 (en) * | 2001-09-19 | 2003-12-25 | Rajneesh Taneja | Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986006632A1 (en) * | 1985-05-10 | 1986-11-20 | Pharmacontrol Corp. | Long-acting antacid compositions |
AUPN033894A0 (en) * | 1994-12-29 | 1995-01-27 | Rowe, J.B. | Prevention of adverse behaviour in humans and animals |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
US6242456B1 (en) * | 1998-03-09 | 2001-06-05 | Trustees Of Tufts College | Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors |
WO2000020016A1 (en) * | 1998-10-06 | 2000-04-13 | Mars U.K. Limited | Animal stereotypy |
-
2000
- 2000-01-15 GB GB0000859A patent/GB2358136A/en not_active Withdrawn
-
2001
- 2001-01-12 AU AU28620/01A patent/AU2862001A/en not_active Abandoned
- 2001-01-12 WO PCT/GB2001/000099 patent/WO2001051064A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB0000859D0 (en) | 2000-03-08 |
GB2358136A (en) | 2001-07-18 |
WO2001051064A1 (en) | 2001-07-19 |
AU2862001A (en) | 2001-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003289888A1 (en) | Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders | |
AU2002337047A1 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
HUP0401293A3 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
AU2002213977A1 (en) | Novel anticholinergics, method for the production thereof and use thereof as medicaments | |
ZA200300712B (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome. | |
WO2002047668A3 (en) | Novel medicament compositions based on anticholinesterase drugs and on ciclesonides | |
IL162669A0 (en) | Antichlinergic agents, method for producing the same and use thereof as medicaments | |
AU2003206760A1 (en) | Anticholinergic agents, method for producing the same and use thereof as medicaments | |
WO2002036106A3 (en) | Novel medicament compositions based on anticholinergics and corticosteroids | |
WO2003000172A3 (en) | Methods, pharmaceutical compositions, oral compositions, filters and tobacco products for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject | |
ZA200500526B (en) | Prodrug, medicinal utilization thereof and process for producing the same | |
WO2004031202A3 (en) | Condensed palatinose in hydrogenated form | |
AU2002366260A1 (en) | Structured surfaces having elevations and depressions, method for producing surfaces of this type and the use thereof | |
CA2417837A1 (en) | Compositions for ameliorating attention-deficient/hyperactivity disorder | |
WO2001060343A3 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers | |
WO2004080477A8 (en) | Aplidine for multiple myeloma treatment | |
WO2001049651A3 (en) | Aminomethyl-phenyl-cyclohexanone derivatives | |
WO2001051064A8 (en) | Ph-regulators against oral stereotypies in equines | |
WO2000061125A3 (en) | Osanetant in the treatment of mood disorders | |
AU2001295979A1 (en) | Medicinal compositions, dose and method for treating malaria | |
AU2001280093A1 (en) | Method for the prevention and treatment of retinopathy | |
AU2002347253A1 (en) | Method for making an oral pharmaceutical product with tell-tale agents, in particular of taste and resulting product | |
WO2002036163A3 (en) | Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses | |
AU2001231278A1 (en) | Apparatus for the dialysis of blood, method for fabricating the same, and methodfor the dialysis of blood | |
AU2002218494A1 (en) | Medicinal compositions and process for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page |
Free format text: REVISED TITLE RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |